Download slides from Clinical Care Options examining the optimal use of VEGFR-targeted TKIs in treating patients with solid organ tumors.
In this activity from Clinical Care Options, experts discuss the latest data on treating solid organ tumors with VEGFR inhibitors.
Download this free slideset by Todd M. Bauer, MD, for a brief overview of the optimal treatment options for patients with NTRK, ROS1, FGFR, or RET altered tumors.
Downloadable PDF resource summarizing FDA-approved immunotherapy indications and complementary diagnostics for PD-L1 in multiple malignancies.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.